nova forma polimórfica de cloridrato de pridopidina

This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANNE ZIMMERMANN, BRIAN FRØSTRUP, CLAS SONESSON, THOMAS PITTELKOW
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANNE ZIMMERMANN
BRIAN FRØSTRUP
CLAS SONESSON
THOMAS PITTELKOW
description This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112014005389A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112014005389A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112014005389A23</originalsourceid><addsrcrecordid>eNrjZDDJyy9LVEjLL8pNVCjIz8nMPby5KC0zOVEhJVUhOSe_KDOlKLEkH8QrALLzCzJTMvMSeRhY0xJzilN5oTQ3g6qba4izh25qQX58anFBYnJqXmpJvFOQoaGRgaGJgYGpsYWlo5ExseoA-xAvLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>nova forma polimórfica de cloridrato de pridopidina</title><source>esp@cenet</source><creator>ANNE ZIMMERMANN ; BRIAN FRØSTRUP ; CLAS SONESSON ; THOMAS PITTELKOW</creator><creatorcontrib>ANNE ZIMMERMANN ; BRIAN FRØSTRUP ; CLAS SONESSON ; THOMAS PITTELKOW</creatorcontrib><description>This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170328&amp;DB=EPODOC&amp;CC=BR&amp;NR=112014005389A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170328&amp;DB=EPODOC&amp;CC=BR&amp;NR=112014005389A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANNE ZIMMERMANN</creatorcontrib><creatorcontrib>BRIAN FRØSTRUP</creatorcontrib><creatorcontrib>CLAS SONESSON</creatorcontrib><creatorcontrib>THOMAS PITTELKOW</creatorcontrib><title>nova forma polimórfica de cloridrato de pridopidina</title><description>This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDJyy9LVEjLL8pNVCjIz8nMPby5KC0zOVEhJVUhOSe_KDOlKLEkH8QrALLzCzJTMvMSeRhY0xJzilN5oTQ3g6qba4izh25qQX58anFBYnJqXmpJvFOQoaGRgaGJgYGpsYWlo5ExseoA-xAvLg</recordid><startdate>20170328</startdate><enddate>20170328</enddate><creator>ANNE ZIMMERMANN</creator><creator>BRIAN FRØSTRUP</creator><creator>CLAS SONESSON</creator><creator>THOMAS PITTELKOW</creator><scope>EVB</scope></search><sort><creationdate>20170328</creationdate><title>nova forma polimórfica de cloridrato de pridopidina</title><author>ANNE ZIMMERMANN ; BRIAN FRØSTRUP ; CLAS SONESSON ; THOMAS PITTELKOW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112014005389A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANNE ZIMMERMANN</creatorcontrib><creatorcontrib>BRIAN FRØSTRUP</creatorcontrib><creatorcontrib>CLAS SONESSON</creatorcontrib><creatorcontrib>THOMAS PITTELKOW</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANNE ZIMMERMANN</au><au>BRIAN FRØSTRUP</au><au>CLAS SONESSON</au><au>THOMAS PITTELKOW</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>nova forma polimórfica de cloridrato de pridopidina</title><date>2017-03-28</date><risdate>2017</risdate><abstract>This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112014005389A2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title nova forma polimórfica de cloridrato de pridopidina
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T09%3A44%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANNE%20ZIMMERMANN&rft.date=2017-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112014005389A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true